Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009861
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-08-16
Brief Title:
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced OralOropharyngeal Cancer NeoSPOT
Sponsor:
Peking University Hospital of Stomatology
Organization:
Peking University Hospital of Stomatology
Organization Data
Organization:
Peking University Hospital of Stomatology
Class:
OTHER
Study ID:
PKUSSIRB-202386047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Hospital of Stomatology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None